Testing effectiveness (Phase 2)Study completedNCT00427557What this trial is testingCellular Therapy With Cord Blood CellsWho this might be right forMultiple MyelomaLeukemiaLymphoma M.D. Anderson Cancer Center 31
Early research (Phase 1)Ended earlyNCT00005787What this trial is testingPeripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forLymphomaNeutropenia Northwestern University 3
Testing effectiveness (Phase 2)Study completedNCT00005804What this trial is testingBone Marrow Transplantation in Treating Patients With Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more Fred Hutchinson Cancer Center
Early research (Phase 1)Ended earlyNCT04553692What this trial is testingPhase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed CancersWho this might be right forSolid TumorColorectal CancerNon Hodgkin Lymphoma+5 more IGM Biosciences, Inc. 272
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07162571What this trial is testingThis is a Phase I/II Interventional, Open-label Treatment Study Designed to Evaluate the Safety and Efficacy of Anti CD 19/22 CAR- T Cells Immunotherapy for Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia/Lymphoma.Who this might be right forAcute Lymphobkastic LeukemiaB Cell Lymphoma Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology 17
Testing effectiveness (Phase 2)Study completedNCT00726700What this trial is testingPegfilgrastim and Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Aggressive B-Cell Non-Hodgkin LymphomaWho this might be right forLymphoma Universität des Saarlandes 109
Large-scale testing (Phase 3)Study completedNCT02005471What this trial is testingEvaluate the Benefit of Venetoclax Plus Rituximab Compared With Bendamustine Plus Rituximab in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)Who this might be right forChronic Lymphocytic Leukemia Hoffmann-La Roche 389
Testing effectiveness (Phase 2)Ended earlyNCT00151736What this trial is testingSafety and Efficacy of SDX-101 (R-Etodolac) in Combination With Chlorambucil, and That of Chlorambucil Alone, in Patients With Chronic Lymphocytic Leukemia (CLL)Who this might be right forChronic Lymphocytic Leukemia Cephalon 88
Large-scale testing (Phase 3)Study completedNCT00052936What this trial is testingCombination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma German High-Grade Non-Hodgkin's Lymphoma Study Group 1,506
Testing effectiveness (Phase 2)Study completedNCT01116193What this trial is testingRepeat-dose Study of Lenalidomide (Revlimid ®) Plus Dexamethasone in Patients With Lymphoblastic LeukemiaWho this might be right forLeukemia, LymphoidPrecursor B-Cell Lymphoblastic Leukemia-Lymphoma Institut de Cancérologie de la Loire 10
Not applicableStudy completedNCT05972577What this trial is testingGeriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS StudyWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAplastic Anemia+9 more Ohio State University Comprehensive Cancer Center 30
Large-scale testing (Phase 3)Study completedNCT01231412What this trial is testingGraft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell TransplantWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAggressive Non-Hodgkin Lymphoma+16 more Fred Hutchinson Cancer Center 174
Post-approval studies (Phase 4)Study completedNCT03190330What this trial is testingAssess Safety of ImbruvicaTM in Indian Participants With Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy or Chronic Lymphocytic Leukemia With 17p DeletionWho this might be right forLeukemia, Lymphocytic, Chronic, B-CellLymphoma, Mantle-Cell Johnson & Johnson Private Limited 75
Large-scale testing (Phase 3)Study completedNCT04502030What this trial is testingDouble-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study)Who this might be right forChronic Lymphocytic LeukemiaHypogammaglobulinemia Octapharma 247
Early research (Phase 1)Study completedNCT01567709What this trial is testingAlisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell LymphomaWho this might be right forAdult B Acute Lymphoblastic LeukemiaAdult T Acute Lymphoblastic LeukemiaAnaplastic Large Cell Lymphoma+32 more National Cancer Institute (NCI) 34
Testing effectiveness (Phase 2)Study completedNCT01008462What this trial is testingAutologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic LeukemiaWho this might be right forB-Cell Prolymphocytic LeukemiaHypodiploidyLoss of Chromosome 17p+18 more Fred Hutchinson Cancer Center 16
Testing effectiveness (Phase 2)Study completedNCT00496873What this trial is testingEvaluation of the Safety and Efficacy of Nipent, Cytoxan, and RituxanWho this might be right forLymphoma M.D. Anderson Cancer Center 100
Not applicableLooking for participantsNCT06508775What this trial is testingLong-Term Follow-up of Patients Treated With Miltenyi Cell and Gene TherapiesWho this might be right forMelanoma Stage IIIB-cell Non Hodgkin LymphomaPediatric ALL+4 more Miltenyi Biomedicine GmbH 40
Very early researchLooking for participantsNCT06346912What this trial is testingCD19-BAFF CAR-T Cells Therapy for Patients With Relapsed / Refractory B-cell ALL and B-cell NHLWho this might be right forAcute Lymphoblastic Leukemia,B-CellNon-hodgkin Lymphoma,B Cell Zhejiang University 20
Testing effectiveness (Phase 2)Study completedNCT00206726What this trial is testingAlemtuzumab/Fludarabine for Relapsed/Refractory B-cell Chronic Lymphocytic Leukemia (B-CLL)Who this might be right forLeukemia, Lymphocytic, Chronic, B-Cell Genzyme, a Sanofi Company 60